The Urotensin II Paradox: Friend or Foe in the Battle Against Acromegaly? Acromegaly, a condition characterized by excessive growth hormone (GH) production, presents a complex medical challenge. Treatment options typically target GH itself or its downstream signaling pathways. However, recent research has shed light on a surprising player in the acromegaly battlefield: urotensin II (UII). … Continue reading The Urotensin II Paradox: Friend or Foe in the Battle Against Acromegaly?